One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Inside This Issue
doi : 10.1016/S1936-8798(22)01956-2
Volume 15, Issue 21, 14 November 2022, Pages A13-A18
Comparative Safety of Transcatheter LAAO With the First-Generation Watchman and Next-Generation Watchman FLX Devices
Matthew J. Price, MD,a Daniel J. Friedman, MD,b Chengan Du, P HD, c,d Youngfei Wang, MS, c,d Zhenqiu Lin, PHD, c,d Jeptha P. Curtis, MD,c,d James V. Freeman, MD, MPH, MS
doi : 10.1016/j.jcin.2022.09.002
Volume 15, Issue 21, 14 November 2022, Pages 2115-2123
Procedural complications limit the clinical benefit of transcatheter left atrial appendage occlusion (LAAO). Next-generation devices incorporate design modifications intended to improve procedural safety, but their clinical impact has not been described.
Striving for Perfection in Transcatheter LAA Closure: One Step Closer With Newer-Generation Devices
Ole De Backer, MD, P HD, Lars Søndergaard, MD, DMS C
doi : 10.1016/j.jcin.2022.09.031
Volume 15, Issue 21, 14 November 2022, Pages 2124-2126
Peridevice Leak After Transcatheter Left Atrial Appendage Occlusion: An Analysis of the Amulet IDE Trial
Matthew J. Price, MD,a Christopher R. Ellis, MD, b Jens Erik Nielsen-Kudsk, MD, c David Thaler, MD, PH D, d Nigel Gupta, MD,e Konstantinos Koulogiannis, MD,f Jordan A. Anderson, P HD, g Ryan Gage, MS, g Dhanunjaya Lakkireddy, MD
doi : 10.1016/j.jcin.2022.09.001
Volume 15, Issue 21, 14 November 2022, Pages 2127-2138
The aim of this study was to assess the incidence of and outcomes associated with PDL in the Amulet IDE (AMPLATZERâ„¢ Amuletâ„¢ LAA Occluder Trial) randomized controlled trial.
Incomplete Transcatheter Left Atrial Appendage Occlusion: No Longer Benign
Mohamad Alkhouli, MD, David R. Holmes, MD
doi : 10.1016/j.jcin.2022.08.049
Volume 15, Issue 21, 14 November 2022, Pages 2139-2142
Sex Differences in Safety and Effectiveness of LAAO: Insights From the Amulet IDE Trial
Mohamad Alkhouli, MD, a Andrea M. Russo, MD, b David Thaler, MD, P HD, c Stephan Windecker, MD,d Jordan A. Anderson, PHD, e Ryan Gage, MS, e Dhanunjaya Lakkireddy, MD
doi : 10.1016/j.jcin.2022.06.037
Volume 15, Issue 21, 14 November 2022, Pages 2143-2155
Women have higher rates of acute complications after left atrial appendage occlusion (LAAO). However, data on long-term safety and effectiveness are limited.
Left Atrial Appendage Occlusion: Sex Matters, But Not in the Long Run
Jens Erik Nielsen-Kudsk, MD, DMS
doi : 10.1016/j.jcin.2022.07.043
Volume 15, Issue 21, 14 November 2022, Pages 2156-2157
Evaluation of Multimodality LAA Leak Closure Methods Following Incomplete Occlusion: The LAA Leak Study
Rishi Charate, MD,a Adnan Ahmed, MD,a Domenico G. Della Rocca, MD, PH D, b Stephen Bloom, MD,a Jalaj Garg, MD,c Naga Venkata K. Pothineni, MD,a Luigi DiBiase, MD, PH D, d Mohit Turagam, MD,e Rakesh Gopinathannair, MD, MA, a Rodney Horton, MD,d Saibal Kar, MD,f Gregory Fontana, MD, f Shephal K. Doshi, MD,g Vijay Swarup, MD,h Aloke Finn, MD, i Vivek Reddy, MD, e Andrea Natale, MD, b Dhanunjaya Lakkireddy, MD
doi : 10.1016/j.jcin.2022.08.034
Volume 15, Issue 21, 14 November 2022, Pages 2158-2170
Incomplete left atrial appendage (LAA) closure is an evolving topic of clinical significance and thromboembolic potential, with recent long-term studies suggesting lower cutoffs for relevant leak size.
Clean Up on Aisle 5 mm: Left Atrial Appendage Device Leak Closure With Detachable Coils, Ablation, and Vascular Plugs
Christopher R. Ellis, MD, Kashish Goel, MD, MBBS
doi : 10.1016/j.jcin.2022.09.003
Volume 15, Issue 21, 14 November 2022, Pages 2171-2173
Functional Patterns of Coronary Disease: Diffuse, Focal, and Serial Lesions
Roberto Scarsini, MD, P HD, a, * Simone Fezzi, MD,a,b, * Antonio Maria Leone, MD, PH D, c Giovanni Luigi De Maria, MD, P HD, d Michele Pighi, MD, a Michele Marcoli, MD, a Domenico Tavella, MD, a Gabriele Pesarini, MD, PHD, a Adrian P. Banning, MD, d Emanuele Barbato, MD, P HD, e,f William Wijns, MD, PHD, b Flavio L. Ribichini, MDa
doi : 10.1016/j.jcin.2022.07.015
Volume 15, Issue 21, 14 November 2022, Pages 2174-2191
The physiological assessment of coronary lesions is influenced by the pattern and distribution of coronary artery disease (CAD), including focal lesions, serial lesions, diffuse disease, and mixed patterns.
Trans-Stent FFR Gradient as a Modifiable Integrant in Predicting Long-Term Target Vessel Failure
Barry F. Uretsky, MD,a,b Shiv Kumar Agarwal, MD, a,b Srikanth Vallurupalli, MD,a,b Malek Al-Hawwas, MD, a,b Kristin Miller, RN,a Simone Biscaglia, MD,e Abdul Hakeem, MDc
doi : 10.1016/j.jcin.2022.08.036
Volume 15, Issue 21, 14 November 2022, Pages 2192-2202
Fractional flow reserve (FFR) after percutaneous coronary intervention (PCI) is associated with long-term outcomes. Data relating FFR-based trans-stent gradient (TSG) after PCI to long-term outcomes are sparse.
The Trans-Stent FFR Gradient: What Is its Role in Contemporary PCI?∗
Kreton Mavromatis, MD,a,b Pratik B. Sandesara, MD
doi : 10.1016/j.jcin.2022.10.001
Volume 15, Issue 21, 14 November 2022, Pages 2203-2205
Impact of Nonobstructive Left Main Coronary Artery Atherosclerosis on Long-Term Mortality
Masahiko Noguchi, MD, PH D, a,b,c Fotios Gkargkoulas, MD, a,b Mitsuaki Matsumura, BS, a Lak N. Kotinkaduwa, PH D, a Xun Hu, MD, a,b Eisuke Usui, MD, PHD, a,b Tatsuhiro Fujimura, MD, PH D, a,b Fumiyasu Seike, MD, PH D, a,b Hanan Salem, MD,a,b Ge Jin, MD,a,b Chenguang Li, MD, a,b Kei Yamamoto, MD, a,b Takao Sato, MD,a,b Bjorn Redfors, MD, a Khady N. Fall, MD, MPH,b Tamim M. Nazif, MD, b Ziad A. Ali, MD, DP HIL,a,b,d Dimitri Karmpaliotis, MD, PH D, e Sahil A. Parikh, MD,b Giora Weisz, MD, b Michael B. Collins, MD, b Lauren T. Privitera, MS, MPH,b LeRoy E. Rabbani, MD, b Martin B. Leon, MD, a,b Jeffery W. Moses, MD, b Gregg W. Stone, MD, a,f Ajay J. Kirtane, MD, SM, a,b Gary S. Mintz, MD,a Akiko Maehara, MD
doi : 10.1016/j.jcin.2022.08.024
Volume 15, Issue 21, 14 November 2022, Pages 2206-2217
Although the presence of severe stenosis in the left main coronary artery (LMCA) is a well-established predictor of mortality, whether this extends to nonobstructive atherosclerosis in the LMCA is unknown.
What You Cannot See Can Hurt You
Sorin Brener, MD
doi : 10.1016/j.jcin.2022.09.017
Volume 15, Issue 21, 14 November 2022, Pages 2218-2220
Bail-Out Emergency Treatment of Left Atrial Perforation After Appendage Occlusion Using Percutaneous Vascular Plug Device
Alessandro Russo, MD, Ahmed Al Mamary, MD, Elisabetta Artuso, MD, Federico Mercanti, MD, Gianmarco Arturo Volpe, MD, Paola Purita, MD, Riccardo Turri, MD, Andrea Pacchioni, MD, Salvatore Saccà , MD
doi : 10.1016/j.jcin.2022.08.007
Volume 15, Issue 21, 14 November 2022, Pages 2221-2224
Multimodality Imaging of Possible Healed Plaque Erosion Pathologically Validated by Directional Coronary Atherectomy Specimens
Eisuke Usui, MD, P HD, a Yoshinori Kanno, MD,a Taishi Yonetsu, MD, PHD, a Yuko Kinowaki, MD, PH D, b Takumi Akashi, MD, P HD, c Tetsuo Sasano, MD, PHD
doi : 10.1016/j.jcin.2022.08.037
Volume 15, Issue 21, 14 November 2022, Pages 2225-2227
Prominent Collateral Vessels in Pulmonary Vein Occlusion: Role of IVUS and a Staged Interventional Approach
Dhruv Sarma, BMBC H,a James Gladden, MD, P HD, b Guy S. Reeder, MD,b Thomas M. Munger, MD,b Douglas L. Packer, MD,b David R. Holmes, MD,b Trevor Simard, MD
doi : 10.1016/j.jcin.2022.08.025
Volume 15, Issue 21, 14 November 2022, Pages e223-e224
Total Occlusion of the Left Main Coronary Artery in Pulmonary Arterial Hypertension
Alejandro Cruz-Utrilla, MD,a MarÃa Jesús Del Cerro MarÃn, MD, PHD, b,c Fernando Sarnago Cebada, MD,d Maite Velázquez MartÃn, MD, P HD, d,e Pilar Escribano Subias, MD, P HD
doi : 10.1016/j.jcin.2022.07.049
Volume 15, Issue 21, 14 November 2022, Pages e225-e226
Retrograde Fenestration of Covered Stent After Left Main–Left Anterior Descending Perforation
Salvatore Colangelo, MD,* Andrea Sardone, MD,* Francesco Colombo, MD, Giacomo Boccuzzi, MD, Mario Iannaccone, MD
doi : 10.1016/j.jcin.2022.07.048
Volume 15, Issue 21, 14 November 2022, Pages e227-e229
Triggering Stent Optimization by Coronary Physiology
Daniel Munhoz, MD, PhD Koshiro Sakai, MD, PhD Carlos Collet, MD, PhD *Takuya Mizukami, MD, PhD
doi : 10.1016/j.jcin.2022.09.010
Volume 15, Issue 21, 14 November 2022, Page 2228
Influence of Diffuse Disease on PCI Optimization: Don’t Forget to Pull Back
Lokien X. van Nunen, MD, PhD *Carlos Collet, MD, PhD
doi : 10.1016/j.jcin.2022.09.009
Volume 15, Issue 21, 14 November 2022, Pages 2228-2229
Reply: Triggering Stent Optimization by Coronary Physiology
Tara Neleman, BSc *Joost Daemen, MD, PhD
Saving the Kidneys Takes a Village
*Ashish Pershad, MD, MS
doi : 10.1016/j.jcin.2022.09.018
Volume 15, Issue 21, 14 November 2022, Pages 2230-2231
Reply: Saving the Kidneys Takes a Village
Philippe Garot, MD Marie-Claude Morice, MD
doi : 10.1016/j.jcin.2022.09.041
Volume 15, Issue 21, 14 November 2022, Page 2231
Atrial Right-to-Left Shunting Does Not Predict PFO Orifice Area in Patients Undergoing Percutaneous PFO Closure
Lars S. Witte, MD Abdelhak el Bouziani, MD Bart Straver, MD, PhD Karel T. Koch, MD, PhD Marcel A.M. Beijk, MD, PhD Leonie Caesar, BSc Jan G.P. Tijssen, PhD Berto J. Bouma, MD, PhD *Robbert J. de Winter, MD, PhD
doi : 10.1016/j.jcin.2022.05.014
Volume 15, Issue 21, 14 November 2022, Pages 2231-2233
10-Year Outcomes After PCI and CABG for Nonbifurcation or Bifurcation LMCA Disease: A Prespecified Analysis of Extended PRECOMBAT Trial
Ah-Ram Kim, MD Do-Yoon Kang, MD, PhD Hwa Jung Kim, MD, PhD Tae Oh Kim, MD, PhD Pil Hyung Lee, MD, PhD Jung-Min Ahn, MD, PhD Seung-Jung Park, MD, PhD *Duk-Woo Park, MD, PhD
doi : 10.1016/j.jcin.2022.08.016
Volume 15, Issue 21, 14 November 2022, Pages 2233-2236
Toward a More Interactive Central Illustration
David J. Moliterno, MD, Editor-in-Chief, JACC: Cardiovascular Interventions
doi : 10.1016/j.jcin.2022.10.006
Volume 15, Issue 21, 14 November 2022, Pages 2237-2238
